O2M Technologies is a preclinical stage medical device company developing novel magnetic resonance oxygen imaging instrumentation and methodologies for cancer radiation treatment targeting. With the O2M team including practicing oncologists and imaging professionals with expertise in cancer biology, instrumentation and software development, O2M specifically uses oxygen information specifically to attack radiation resistant cancer tissues and avoid unnecessary damage to other areas which reduces post-treatment complications and improves cancer treatment success.
